Journal of Reproductive Immunology
Volume 83, Issue 1 , Pages 185-189 , December 2009

Impact of T. vaginalis infection on innate immune responses and reproductive outcome

Received 16 March 2009 ,Revised 23 August 2009 ,Accepted 31 August 2009.

References 

  1. Al-Mohammed HI, Hussein EM. Comparison between secretory leukocytic protease inhibitor and reactive nitrogen intermediates levels in cervicovaginal secretions from symptomatic and asymptomatic trichomoniasis Egyptians patients. J. Egypt Soc. Parasitol. 2006;36:763–777
  2. Alderete JF, Kasmala L, Metcalfe E, Garza GE. Phenotypic variation and diversity among Trichomonas vaginalis isolates and correlation of phenotype with trichomonal virulence determinants. Infect. Immun. 1986;53:285–293
  3. Bastida-Corcuera FD, Okumura CY, Colocoussi A, Johnson PJ. Trichomonas vaginalis lipophosphoglycan mutants have reduced adherence and cytotoxicity to human ectocervical cells. Eukaryot. Cell. 2005;4:1951–1958
  4. Benchimol M, de Andrade Rosa I, da Silva Fontes R, Burla Dias AJ. Trichomonas adhere and phagocytose sperm cells: adhesion seems to be a prominent stage during interaction. Parasitol. Res. 2008;102:597–604
  5. Caliendo AM, Jordan JA, Green AM, Ingersoll J, Diclemente RJ, Wingood GM. Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs. Infect. Dis. Obstet. Gynecol. 2005;13:145–150
  6. Carlton JM, Hirt RP, Silva JC, Delcher AL, Schatz M, Zhao Q, et al. Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science. 2007;315:207–212
  7. Cauci S, Culhane JF. Modulation of vaginal immune response among pregnant women with bacterial vaginosis by Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, and yeast. Am. J. Obstet. Gynecol. 2007;196, 133:e131–137
  8. Chang J-H, Park J-Y, Kim S-K. Dependence on p38 MAPK signalling in the up-regulation of TLR2, TLR4 and TLR9 gene expression in Trichomonas vaginalis-treated HeLa cells. Immunology. 2006;118:164–170
  9. Chang JH, Kim SK, Choi IH, Lee SK, Morio T, Chang EJ. Apoptosis of macrophages induced by Trichomonas vaginalis through the phosphorylation of p38 mitogen-activated protein kinase that locates at downstream of mitochondria-dependent caspase activation. Int. J. Biochem. Cell Biol. 2006;38:638–647
  10. Chang JH, Ryang YS, Morio T, Lee SK, Chang EJ. Trichomonas vaginalis inhibits proinflammatory cytokine production in macrophages by suppressing NF-kappaB activation. Mol. Cells. 2004;18:177–185
  11. Draper D, Donohoe W, Mortimer L, Heine RP. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor. J. Infect. Dis. 1998;178:815–819
  12. Fichorova RN, Rheinwald JG, Anderson DJ. Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol. Reprod. 1997;57:847–855
  13. Fichorova RN, Trifonova RT, Gilbert RO, Costello CE, Hayes GR, Lucas JJ, et al. Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect. Immun. 2006;74:5773–5779
  14. Fichorova RN, Trifonova RT, Singh BN. T. vaginalis LPG regulates cytokine responses via binding galectins on human vaginal epithelial cells. Microbicides. 2008;New Delhi, India www.microbicides2008.com
  15. Fogel S, Guittaut M, Legrand A, Monsigny M, Hebert E. The tat protein of HIV-1 induces galectin-3 expression. Glycobiology. 1999;9:383–387
  16. Huang K-Y, Chien K-Y, Lin Y-C, Hsu W-M, Fong IK, Huang P-J, et al. A proteome reference map of Trichomonas vaginalis. Parasitol. Res. 2009;104:927–933
  17. Johnson LF, Coetzee DJ, Dorrington RE. Sentinel surveillance of sexually transmitted infections in South Africa: a review. Sex Transm. Infect. 2005;81:287–293
  18. Kang JH, Song HO, Ryu JS, Shin MH, Kim JM, Cho YS, et al. Trichomonas vaginalis promotes apoptosis of human neutrophils by activating caspase-3 and reducing Mcl-1 expression. Parasite Immunol. 2006;28:439–446
  19. Kaur S, Khurana S, Bagga R, Wanchu A, Malla N. Antitrichomonas IgG, IgM, IgA, and IgG subclass responses in human intravaginal trichomoniasis. Parasitol. Res. 2008;103:305–312
  20. Kucknoor A, Mundodi V, Alderete JF. Trichomonas vaginalis adherence mediates differential gene expression in human vaginal epithelial cells. Cell Microbiol. 2005;7:887–897
  21. Kucknoor AS, Mundodi V, Alderete JF. Adherence to human vaginal epithelial cells signals for increased expression of Trichomonas vaginalis genes. Infect. Immun. 2005;73:6472–6478
  22. Kucknoor AS, Mundodi V, Alderete JF. The proteins secreted by Trichomonas vaginalis and vaginal epithelial cell response to secreted and episomally expressed AP65. Cell Microbiol. 2007;9:2586–2597
  23. Lanteri M, Giordanengo V, Hiraoka N, Fuzibet J-G, Auberger P, Fukuda M, et al. Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death. Glycobiology. 2003;13:909–918
  24. Malla N, Yadav M, Gupta I. Kinetics of serum and local cytokine profile in experimental intravaginal trichomoniasis induced with Trichomonas vaginalis isolates from symptomatic and asymptomatic women. Parasite Immunol. 2007;29:101–105
  25. McClelland RS. Trichomonas vaginalis infection: can we afford to do nothing?. J. Infect. Dis. 2008;197:487–489
  26. Mercier S, St-Pierre C, Pelletier I, Ouellet M, Tremblay MJ, Sato S. Galectin-1 promotes HIV-1 infectivity in macrophages through stabilization of viral adsorption. Virology. 2008;371:121–129
  27. Nieminen J, St-Pierre C, Bhaumik P, Poirier F, Sato S. Role of galectin-3 in leukocyte recruitment in a murine model of lung infection by Streptococcus pneumoniae. J. Immunol. 2008;180:2466–2473
  28. Okumura CY, Baum LG, Johnson PJ. Galectin-1 on cervical epithelial cells is a receptor for the sexually transmitted human parasite Trichomonas vaginalis. Cell Microbiol. 2008;10:2078–2090
  29. Okun N, Gronau KA, Hannah ME. Antibiotics for bacterial vaginosis or Trichomonas vaginalis in pregnancy: a systematic review. Obstet. Gynecol. 2005;105:857–868
  30. Rabinovich GA, Gruppi A. Galectins as immunoregulators during infectious processes: from microbial invasion to the resolution of the disease. Parasite Immunol. 2005;27:103–114
  31. Ryu JS, Kang JH, Jung SY, Shin MH, Kim JM, Park H, et al. Production of interleukin-8 by human neutrophils stimulated with Trichomonas vaginalis. Infect. Immun. 2004;72:1326–1332
  32. Sena AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin. Infect. Dis. 2007;44:13–22
  33. Shafir SC, Sorvillo FJ, Smith L. Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin. Microbiol. Rev. 2009;22:37–45
  34. Shaio MF, Lin PR, Lee CS, Hou SC, Tang P, Yang KD. A novel neutrophil-activating factor released by Trichomonas vaginalis. Infect. Immun. 1992;60:4475–4482
  35. Shaio MF, Lin PR, Liu JY, Yang KD. Generation of interleukin-8 from human monocytes in response to Trichomonas vaginalis stimulation. Infect. Immun. 1995;63:3864–3870
  36. Simhan HN, Anderson BL, Krohn MA, Heine RP, Martinez de Tejada B, Landers DV, et al. Host immune consequences of asymptomatic Trichomonas vaginalis infection in pregnancy. Am. J. Obstet. Gynecol. 2007;196, 59:e51–55
  37. Singh BN, Hayes GR, Lucas JJ, Sommer U, Viseux N, Mirgorodskaya E, et al. Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function. Glycoconjugate J. 2009;26:3–17
  38. Singh BN, Lucas JJ, Fichorova RN. Trichomonas vaginalis: pathobiology and pathogenesis. In:  Khan NA, et al. editor. Emerging Protozoan Pathogens. London, UK: Taylor & Francis Group; 2007;p. 411–455
  39. Smith LM, Wang M, Zangwill K, Yeh S. Trichomonas vaginalis infection in a premature newborn. J. Perinatol. 2002;22:502–503
  40. Sommer U, Costello CE, Hayes GR, Beach DH, Gilbert RO, Lucas JJ, et al. Identification of Trichomonas vaginalis cysteine proteases that induce apoptosis in human vaginal epithelial cells. J. Biol. Chem. 2005;280:23853–23860
  41. Than NG, Erez O, Wildman DE, Tarca AL, Edwin SS, Abbas A, et al. Severe preeclampsia is characterized by increased placental expression of galectin-1. J. Matern. Fetal Neonat. Med. 2008;21:429–442
  42. Than NG, Kim SS, Abbas A, Han YM, Hotra J, Tarca AL, et al. Chorioamnionitis and increased galectin-1 expression in PPROM—an anti-inflammatory response in the fetal membranes?. Am. J. Reprod. Immunol. 2008;60:298–311
  43. Van Der Pol B, Williams JA, Orr DP, Batteiger BE, Fortenberry JD. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J. Infect. Dis. 2005;192:2039–2044
  44. Vanacova S, Liston DR, Tachezy J, Johnson PJ. Molecular biology of the amitochondriate parasites, Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. Int. J. Parasitol. 2003;33:235–255
  45. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect. Sex Reprod. Health. 2004;36:6–10
  46. Yadav M, Dubey ML, Gupta I, Malla N. Cysteine proteinase 30 (CP30) and antibody response to CP30 in serum and vaginal washes of symptomatic and asymptomatic Trichomonas vaginalis infected women. Parasite Immunol. 2007;29:359–365
  47. Yadav M, Gupta I, Malla N. Kinetics of immunoglobulin G, M, A and IgG subclass responses in experimental intravaginal trichomoniasis: prominence of IgG1 response. Parasite Immunol. 2005;27:461–467
  48. Zariffard MR, Harwani S, Novak RM, Graham PJ, Ji X, Spear GT. Trichomonas vaginalis infection activates cells through toll-like receptor 4. Clin. Immunol. 2004;111:103–107
  49. Zubácová Z, Cimburek Z, Tachezy J. Comparative analysis of trichomonad genome sizes and karyotypes. Mol. Biochem. Parasitol. 2008;161:49–54

PII: S0165-0378(09)00449-5

doi: 10.1016/j.jri.2009.08.007

Journal of Reproductive Immunology
Volume 83, Issue 1 , Pages 185-189 , December 2009

Article Tools